King's College London

Research portal

Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).

Research output: Contribution to journalMeeting Abstractpeer-review

Courtney Denton Dinardo, Andre C. Schuh, Eytan M. Stein, Pau Montesinos, Andrew Wei, Stephane De Botton, Amer Methqal Zeidan, Amir Tahmasb Fathi, Lynn Quek, Hagop M. Kantarjian, Mark G. Frattini, Frederik Lersch, Jing Gong, Aleksandra Franovic, Paresh Vyas, Hartmut Dohner

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number15
Published20 May 2020

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454